Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An internist's update on cholesterol management.

Honey East Holman1, G Swink Hicks, Annette K Low

  • 1Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505, USA. hholman@medicine.umsmed.edu

The American Journal of the Medical Sciences
|October 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

BMC genetics·2015
Same author

Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study.

Circulation·2013
Same author

Efficacy of a school-based childhood obesity intervention program in a rural southern community: TEAM Mississippi Project.

Obesity (Silver Spring, Md.)·2011
Same author

Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.

Pediatric blood & cancer·2009
Same author

Ethical dilemmas in coding domestic violence.

The Journal of clinical ethics·2009
Same author

Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication.

Molecular cytogenetics·2008
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Coronary heart disease (CHD) is a leading cause of death, with cholesterol as a key risk factor. This review covers dyslipidemia classification, hyperlipidemia treatment, and emerging CHD risk factors.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Coronary heart disease (CHD) is the primary cause of mortality in the United States.
  • Cholesterol is recognized as a significant and modifiable risk factor for CHD development.
  • Dyslipidemias, or abnormal blood lipid levels, are central to CHD pathogenesis.

Purpose of the Study:

  • To provide a background on the classification of dyslipidemias.
  • To discuss current guidelines for evaluating and treating hyperlipidemia.
  • To explore other investigated risk factors associated with CHD.

Main Methods:

  • Literature review of dyslipidemia classification.
  • Analysis of current clinical practice guidelines for hyperlipidemia management.

Related Experiment Videos

  • Synthesis of research on emerging CHD risk factors.

    • Main Results:

    • Established classification systems for various dyslipidemias.
    • Current evidence-based recommendations for lipid management.
    • Identification of ongoing research into novel CHD risk factors.

    Conclusions:

    • Effective management of hyperlipidemia is crucial for reducing CHD mortality.
    • Understanding dyslipidemia classification aids in targeted treatment strategies.
    • Continued research is necessary to fully elucidate and address all CHD risk factors.